Document is current
Any future updates will be listed below
-
Authors
Todoric, Jelena https://orcid.org/0000-0002-2669-3904
Di Caro, Giuseppe
Reibe, Saskia
Henstridge, Darren C. https://orcid.org/0000-0003-4988-767X
Green, Courtney R. https://orcid.org/0000-0002-9279-0649
Vrbanac, Alison
Ceteci, Fatih
Conche, Claire
McNulty, Reginald https://orcid.org/0000-0003-2101-1377
Shalapour, Shabnam
Taniguchi, Koji
Meikle, Peter J. https://orcid.org/0000-0002-2593-4665
Watrous, Jeramie D.
Moranchel, Rafael
Najhawan, Mahan https://orcid.org/0000-0003-4027-1203
Jain, Mohit
Liu, Xiao
Kisseleva, Tatiana
Diaz-Meco, Maria T. https://orcid.org/0000-0003-0147-0998
Moscat, Jorge https://orcid.org/0000-0002-9442-3834
Knight, Rob https://orcid.org/0000-0002-0975-9019
Greten, Florian R. https://orcid.org/0000-0002-3928-6080
Lau, Lester F. https://orcid.org/0000-0002-4364-2914
Metallo, Christian M.
Febbraio, Mark A. https://orcid.org/0000-0002-9296-4418
Karin, Michael https://orcid.org/0000-0002-2758-6473
- License Information
-
More Information
Article History
Received: 2 December 2019
Accepted: 13 July 2020
First Online: 24 August 2020
Competing interests
: M.K. holds a US patent on the use of <i>MUP-uPA</i> mice to study NASH and HCC (10,034,462 B2) and had received research support from Jansen Pharmaceuticals. All other authors declare no competing interests.
